TRPV1: A Target for Rational Drug Design

By Carnevale Vincenzo   Rohacs Tibor  

Pharmaceuticals, Vol. 9, Iss. 3, 2016-08 ,pp. : 52-52

MDPI

Access to resources Recommend Favorite

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

By Camins Antoni   Junyent Felix   Verdaguer Ester   Beas-Zarate Carlos   Rojas-Mayorquín Argelia E.   Ortuño-Sahagún Daniel   Pallàs Mercè  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 194-205

MDPI

Access to resources Recommend Favorite

TRPV3 in Drug Development

By Broad Lisa M.   Mogg Adrian J.   Eberle Elizabeth   Tolley Marcia   Li Dominic L.   Knopp Kelly L.  

Pharmaceuticals, Vol. 9, Iss. 3, 2016-09 ,pp. : 55-55

MDPI

Access to resources Recommend Favorite

Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells

By Sadofsky Laura R.   Sreekrishna Koti T.   Lin Yakang   Schinaman Renee   Gorka Kate   Mantri Yogita   Haught John Christian   Huggins Thomas G.   Isfort Robert J.   Bascom Charles C.   Morice Alyn H.  

Cells, Vol. 3, Iss. 2, 2014-06 ,pp. : 616-626

MDPI

Access to resources Recommend Favorite

Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

By Chen Thomas C.   Da Fonseca Clovis O.   Schönthal Axel H.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1463-1463

MDPI

Access to resources Recommend Favorite